Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-019-7 | CAS number: 7783-66-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 100
- Absorption rate - dermal (%):
- 10
- Absorption rate - inhalation (%):
- 100
Additional information
Metabolism
Iodine pentafluoride is a highly reactive and corrosive substance which undergoes an immediate decomposition in contact with water or moisture according to the following reaction scheme: IF5 + 3 H2O → HIO3+ 5HF
Thus, one mole of iodic acid and five moles of hydrofluoric acid are formed as a result of the reaction of one mole IF5 with water. Both iodic acid and hydrofluoric acid are relatively strong acids and will undergo dissociation into their respective protons and anions in aqueous media, forming iodate and fluoride.
Available toxicokinetic data on iodate indicate that upon uptake in the body at least at low concentrations it is quantitatively reduced to iodide by a non-enzymatic reaction (Bürgi, 2001). Leblond and Süe (1941) reported that within 40 minutes after rats were exposed intravenously to radioactive iodate containing 0.75 mg radioactive iodine, all iodate was converted into iodide. Olsen et al. (1979) reported a half-life of 14 minutes when rabbits received an intravenous injection of 30 mg/kg bw radiolabelled sodium iodate. These results are similar to those reported by Taurog et al. (1966), who reported that following the intravenous administration of 0.75 µmol of radioiodate (95 µg iodine) to rats or 8 µmol of radioiodate (1 mg iodine) to rabbits, within 3 minutes radioiodate could no longer be detected in the blood, and all the administered radioactive iodine was in the form of iodide. Webster et al. (1966) administered a higher single dose of 200 mg/kg bw potassium iodate to three mongrel dogs; during the first 24 hours both iodate and iodide were present in the urine. During the next 24-48 hours the iodide diminished and the iodate disappeared. Within 4 days only traces of iodide were present in the urine. Ingestion of 60 mg/kg bw potassium iodate, resulted in the appearance of iodate in the urine only for a brief time within a few hours after ingestion, and the amount relative to the quantity of iodide was small. These observations indicate that much of the iodate is reduced to iodide in the body.
Taurog et al. (1966) demonstrated that the reduction of iodate in the body is a non-enzymatic process and depends on the availability of sulfhydryl groups, e.g. in glutathione. The reaction between iodate and glutathione proceeds as follows: 6 GSH + IO3-→ 3 G-S-S-G + I-+ 3 H2O. Available data indicate that other –SH groups in e.g. haemoglobin and in other proteins may also be oxidised by iodate. Overall, the available data provide convincing evidence that at least at low doses iodate is quantitatively reduced by non-enzymatic reactions and becomes available to the body as iodide. Therefore, exposure of tissues to iodate, with the exception of perhaps the gastrointestinal mucosa, might be limited. At high doses, however, the bodily capacity of iodate-reducing –SH-containing proteins might be exhausted, which leads to a part of iodate being excreted unmetabolised, as observed by Webster et al. (1966) in dogs. However, the dose of 200 mg/kg bw at which the excretion of both iodate and iodide was observed, was severely toxic to dogs, with one out of three animals dying within a week. At a lower dose of 60 mg/kg bw, at which already most of the iodate was converted into iodide within a few hours, also clinical signs of toxicity, including vomiting, were noted.
Absorption
Initially, DNEL derivation was based on the LOAEL determined in a two-year oral rat study with potassium iodide, using the REACH default absorption values for extrapolation from the oral route to the inhalation and dermal routes. For final DNEL derivation the human Tolerable Daily Intake for iodine established by WHO was used. In this derivation human absorption data were used to perform route-to-route extrapolation. An oral and inhalation absorption of 100% was assumed since inorganic compounds of iodine are readily and extensively absorbed by both the inhalation and oral routes (WHO, 2009). For dermal absorption, a ratio oral to dermal absorption of 10:1 was used since dermal absorption in humans has been experimentally shown to be 1% or less of the applied dose (WHO, 2009), but as IF5 is a corrosive substance, the integrity of the skin could be compromised and therefore a dermal absorption of 10% was assumed.
-WHO (2009). Concise International Chemical Assessment Document 72. Iodine and inorganic iodides: Human health aspects. Geneva, World Health Organization.Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.